𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P11 Long-range temporal correlations in the subthalamic nucleus of patients with Parkinson’s disease

✍ Scribed by F.U. Hohlefeld; J. Hübl; G.H. Schneider; A.A. Kühn; G. Curio; V.V. Nikulin

Book ID
119192783
Publisher
Elsevier
Year
2011
Tongue
English
Weight
38 KB
Volume
1
Category
Article
ISSN
2210-5336

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mortality in patients with Parkinson's d
Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus
✍ Michael W.M. Schüpbach; Marie Laure Welter; Anne Marie Bonnet; Alexis Elbaz; Bra 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract Subthalamic nucleus (STN) stimulation improves motor disability and quality of life in patients with advanced Parkinson's disease (PD). Short‐term mortality is low, but little is known about long‐term mortality. We assessed mortality and causes of death in 171 consecutive PD patients tr

Beta activity in the subthalamic nucleus
Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease
✍ Elena Urrestarazu; Jorge Iriarte; Manuel Alegre; Pedro Clavero; Mari Cruz Rodríg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 1 views

## Abstract The recordings of local field potentials in the subthalamic nucleus in patients with Parkinson's disease (PD), carried out through the stimulators implanted to treat the motor symptoms of the disease, show a prominent basal (“off”) activity in the beta range, which is attenuated after d

Replacement of dopaminergic medication w
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: Long-term observation
✍ Luigi M. Romito; Maria Fiorella Contarino; Nicola Vanacore; Anna Rita Bentivogli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract Stimulation of the subthalamic nucleus (STN) is an effective treatment for advanced Parkinson's disease (PD), but the medication requirements after implant are poorly known. We performed a long‐term prospective evaluation of 20 patients maintained at stable dopaminergic therapy for 5 ye